OLFML2A and leukemia: Consistent with these findings, Dai et al. showed that OLFML2A is also overexpressed in liver hepatocellular carcinoma (LIHC) and many other cancers, such as breast cancer and leukemia, by comparing the Oncomine dataset to normal samples (13).